EUDA Health Holdings Limited (EUDA) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

Per the Roarable RQD rating, EUDA scores 35 out of 100, earning a letter grade of D- and the verdict label "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars are:

• Fundamental Cash Engine (4 / 20): Per the Roarable RQD rating, this pillar reflects an ROIC of -35% and an FCF yield of -5.39%. Returns on invested capital are negative, and the business is not currently generating free cash flow relative to its market value. This is the weakest-scoring pillar in relative terms and the most direct signal that the operating model is not yet self-funding.
• Whale 13F Flow (7 / 20): Per the Roarable RQD rating, institutional accumulation and options positioning score low. Because the holders section contains no data, the source cannot confirm the direction or size of institutional interest.
• Insider Conviction (3 / 20): Per the Roarable RQD rating, SEC Form 4 and Congressional PTR cluster flow score the lowest of the five pillars. No insider transaction data is available in the source to explain this score.
• Macro Regime Fit (10 / 20): Per the Roarable RQD rating, the beta of 1.0 and sector sensitivity place this pillar at mid-range. The stock is assessed as moving in line with the broader market.
• Forensic Balance Sheet (11 / 20): Per the Roarable RQD rating, the Altman Z of 2.5, Piotroski F of 4/9, and Debt/Equity of 0.5 produce a moderate score. This is the strongest pillar, but it is still below the midpoint.

For a prospective investor evaluating the stock today, the implication is that the rating is driven primarily by negative operating economics, with the balance sheet being the relatively stronger component. Upside drivers, if any, would need to come from a turn in operating returns that the source data does not yet show. The valuation tradeoff is that a market capitalization of $46.4M sits against reported operating losses, so the price reflects expectations the reported figures do not currently support.

EUDA Health Holdings Limited is a NASDAQ-listed issuer in the Health Care sector, operating within the Medical/Nursing Services industry, per the SEC profile. The source data does not describe its specific products, services, customers, or revenue model. Reported revenue of $6.8M for FY 2025 indicates an operating business with a commercial revenue base, per the SEC financials. The gross margin of 43.9% per the market data suggests the company retains a portion of revenue after direct costs.

Per the SEC financials, revenue grew from $3.7M in FY 2023 to $6.8M in FY 2025, while operating losses narrowed from $-17.3M in FY 2024 to $-2.5M in FY 2025. Per the market data, the operating margin is -36.3% and the net margin is -40.7%, with ROIC at -35%. Per the Roarable RQD rating, the Altman Z-Score is 2.5 and the Piotroski F-Score is 4/9, with a Debt/Equity ratio of 0.5, which together describe a balance sheet that is not in distress but shows limited strength on the Piotroski measure.

Per the Butterfly Supply-Chain Graph, the supply chain is listed as NONE, with no butterfly links and no proprietary signals. Upstream and downstream dependencies, sector correlations, and second-order bottlenecks cannot be mapped from the source data.

• What are the specific products, services, and customers that generate the reported $6.8M in FY 2025 revenue?
• What drove the decline in operating loss from $-17.3M in FY 2024 to $-2.5M in FY 2025, and is that trend sustainable?
• What are the cash and debt balances behind the Debt/Equity ratio of 0.5 and the Piotroski F-Score of 4/9?
• Why does the 52-week range span from $5.26 to $71.2, and what events drove that volatility?
• What is the source of the $46.4M market capitalization relative to reported operating losses?